
The Centers for Disease Control and Prevention (CDC) has narrowed its recommendations for which older adults should get a vaccine against respiratory syncytial virus (RSV). It now states that only adults 75 and older, or those ages 60 to 74 who are at high risk, should get the shot.
That's partly because the vaccine may slightly increase the risk of a rare side effect that can sometimes lead to paralysis or death.